Titolo	Data di pubblicazione	Autore(i)
1	Vitamin D pathway polymorphisms impact on HBV interferon treatment outcomes in a cohort of HBeAg negative patients	2015	Cusato, Jessica; Boglione, Lucio; De Nicolo’, Amedeo; Cardellino, Chiara Simona; Imbornone, Rosaria; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
2	Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients	2018	Cusato, Jessica; De Nicolò, Amedeo; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Carcieri, Chiara; Guido, Federica; Avataneo, Valeria; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
3	Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Baietto, Lorena; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
4	Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia	2016	Cusato, Jessica; Boglione, Lucio; DE NICOLO', Amedeo; Cardellino, Chiara Simona; Carcieri, Chiara; Cariti, Giuseppe; DI PERRI, Giovanni; D'Avolio, Antonio
5	Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs	2018	Cusato, Jessica; Boglione, Lucio; De Nicolò, Amedeo; Favata, Fabio; Ariaudo, Alessandra; Mornese Pinna, Simone; Guido, Federica; Avataneo, Valeria; Cantù, Marco; Carcieri, Chiara; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
6	Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy	2018	Cusato, Jessica; Nicolò, Amedeo De; Boglione, Lucio; Favata, Fabio; Ariaudo, Alessandra; Pinna, Simone Mornese; Carcieri, Chiara; Guido, Federica; Cariti, Giuseppe; Perri, Giovanni Di; D'Avolio, Antonio
7	VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; DE NICOLO', Amedeo; Cariti, G; DI PERRI, Giovanni; D'Avolio, Antonio
8	VDR gene polymorphisms impact on anemia at 2 week of anti-HCV therapy: a possible mechanism for early RBV-induced anemia.	2015	Cusato, Jessica; Allegra, Sarah; Boglione, Lucio; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D’Avolio, Antonio
9	Ultra Performance Liquid Chromatography PDA Method for Determination of Tigecycline in Human Plasma.	2013	D'Avolio A;Peila E;Simiele M;Pensi D;Baietto L;Cusato J;Cinnirella G;De Rosa F;Di Perri G
10	UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples	2017	DE NICOLO', Amedeo; Avataneo, Valeria; Rabbia, Franco; Sciandra, Mauro; Tosello, Francesco; Cusato, Jessica; Perlo, Elisa; Mulatero, Paolo; Veglio, Franco; DI PERRI, Giovanni; D'Avolio, Antonio
11	UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients	2016	DE NICOLO', Amedeo; Avataneo, Valeria; Rabbia, Franco; Bonifacio, Gabriele; Cusato, Jessica; Tomasello, Cristina; Perlo, Elisa; Mulatero, Paolo; Veglio, Franco; DI PERRI, Giovanni; D'Avolio, Antonio
12	UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients	2016	DE NICOLO', Amedeo; Bonifacio, Gabriele; Boglione, Lucio; Cusato, Jessica; Pensi, Debora; Tomasello, Cristina; DI PERRI, Giovanni; D'Avolio, Antonio
13	Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study	2017	Boglione, Lucio; Cardellino, Chiara Simona; Cusato, Jessica; De Nicolò, Amedeo; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
14	Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: a prospective study	2017	Boglione, Lucio; Mornese Pinna, Simone; De Nicolò, Amedeo; Cusato, Jessica; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
15	Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors	2017	Boglione, Lucio; Pinna, Simone Mornese; Cardellino, Chiara Simona; De Nicolò, Amedeo; Cusato, Jessica; Carcieri, Chiara; Cariti, Giuseppe; Di Perri, Giovanni; D'Avolio, Antonio
16	Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stage	2015	Lucio Boglione; Jessica Cusato; Giuseppe Cariti; Giovanni Di Perri; Antonio D’Avolio
17	Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children	2018	Allegra, Sarah; Fatiguso, Giovanna; De Francia, Silvia; Favata, Fabio; Pirro, Elisa; Carcieri, Chiara; De Nicolò, Amedeo; Cusato, Jessica; Di Perri, Giovanni; D'Avolio, Antonio
18	Therapeutic drug monitoring guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence	2018	Avataneo, Valeria; De Nicolò, Amedeo; Rabbia, Franco; Perlo, Elisa; Burrello, Jacopo; Berra, Elena; Pappaccogli, Marco; Cusato, Jessica; D'Avolio, Antonio; Di Perri, Giovanni; Veglio, Franco
19	Tenofovir disoproxil fumarate discontinuation for renal outcomes: any room for treatment personalization?	2019	Calcagno, A; Fiumanò, M; Zugna, D; Cusato, J; Montrucchio, C; Marinaro, L; Trentini, L; Ferrara, M; D'Avolio, A; Pizzi, C; Di Perri, G; Bonora, S
20	Tenofovir clearance is reduced in hiv-positive patients with subclinical tubular impairment	2016	Calcagno, A; Cusato, J; Marinaro, L; Simiele, M; Lucchiari, M; Alcantarini, C; Tettoni, M C; Trentini, L; Mengozzi, G; D'Avolio, A; Di Perri, G; Bonora, S